McMaster Perspective

  • COVID-19: To treat or not to treat? Platform trials

    COVID-19: To treat or not to treat? Platform trials

    Dr Edward Mills, associate professor in the Department of Health Research Methods, Evidence, and Impact, clinical trials advisor at the Bill & Melinda Gates Foundation, and senior principal scientist at Cytel, clarifies the concept of platform trials and their significance during the pandemic.

  • COVID-19: To treat or not to treat? May 4 update

    COVID-19: To treat or not to treat? May 4 update

    Dr Jean-Louis Vincent, professor of intensive care medicine at Université libre de Bruxelles and past president of the World Federation of Societies of Intensive and Critical Care Medicine, talks about the current situation in Belgium and effectiveness of available treatments.

  • COVID-19: To treat or not to treat? April 26 update

    COVID-19: To treat or not to treat? April 26 update

    Dr R. Phillip Dellinger, senior critical care attending at Cooper University Health Care, past president of the Society of Critical Care Medicine, and lead author of sepsis guidelines, talks about some of the striking features of COVID-19 and current patterns of practice.

  • COVID-19: To treat or not to treat? April 22 update

    COVID-19: To treat or not to treat? April 22 update

    Dr Miłosz Parczewski, head of the Polish Scientific AIDS Society, reviews some hypotheses about SARS-CoV-2 and takes a closer look at the potential drugs under investigation.

  • COVID-19: To treat or not to treat? April 21 update

    COVID-19: To treat or not to treat? April 21 update

    Dr Gordon Guyatt, distinguished professor in the Department of Health Research Methods, Evidence, and Impact at McMaster University and one of the founders of EBM, discusses the rationale behind making treatment decisions in patients with COVID-19.

  • COVID-19: To treat or not to treat? April 15 update. Part 2

    COVID-19: To treat or not to treat? April 15 update. Part 2

    Dr Jean-Louis Vincent, professor of intensive care medicine at Université libre de Bruxelles and past president of the World Federation of Societies of Intensive and Critical Care Medicine, discusses the currently available treatment options for COVID-19.

  • COVID-19: To treat or not to treat? April 15 update. Part 1

    COVID-19: To treat or not to treat? April 15 update. Part 1

    Dr Jean-Louis Vincent, professor of intensive care medicine at Université libre de Bruxelles and past president of the World Federation of Societies of Intensive and Critical Care Medicine, discusses the currently available treatment options for COVID-19.

  • COVID-19: To treat or not to treat? April 14 update

    COVID-19: To treat or not to treat? April 14 update

    Dr Bram Rochwerg, assistant professor in the Division of Critical Care and medical lead in the intensive care unit at the Juravinski Hospital, discusses the currently available treatment options for COVID-19 and their use outside of clinical trials.

  • COVID-19: To treat or not to treat? April 14 update

    COVID-19: To treat or not to treat? April 14 update

    Dr Roman Jaeschke, professor in the Department of Medicine and physician lead of the Critical Care Response Team at St Joseph’s Healthcare Hamilton, considers fundamental questions regarding treatment of COVID-19.

  • COVID-19: CPGs for critically ill patients. Part 7: Other therapeutics

    COVID-19: CPGs for critically ill patients. Part 7: Other therapeutics

    Dr Waleed Alhazzani, lead author of the newest SSC guidelines, talks us through the evidence behind different treatment options (IVIG, antivirals, antimalarials).

186 articles - page 9 of 19

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.